CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

  • 12/02/2026

Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth

  • 12/02/2026

Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research

  • 11/02/2026
×Close